Ray S - Search Results

1

A topical parathyroid hormone/parathyroid hormone-related peptide receptor antagonist stimulates hair growth in mice.

Safer JD, Ray S, Holick MF. Safer JD, et al. Among authors: ray s. Endocrinology. 2007 Mar;148(3):1167-70. doi: 10.1210/en.2006-1442. Epub 2006 Dec 14. Endocrinology. 2007. PMID: 17170098

2

Thyroid hormone action on skin: diverging effects of topical versus intraperitoneal administration.

Safer JD, Crawford TM, Fraser LM, Hoa M, Ray S, Chen TC, Persons K, Holick MF. Safer JD, et al. Among authors: ray s. Thyroid. 2003 Feb;13(2):159-65. doi: 10.1089/105072503321319468. Thyroid. 2003. PMID: 12699590

3

A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice.

Holick MF, Ray S, Chen TC, Tian X, Persons KS. Holick MF, et al. Among authors: ray s. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8014-6. doi: 10.1073/pnas.91.17.8014. Proc Natl Acad Sci U S A. 1994. PMID: 8058749 Free PMC article.

4

Control of hair growth with parathyroid hormone (7-34).

Schilli MB, Ray S, Paus R, Obi-Tabot E, Holick MF. Schilli MB, et al. Among authors: ray s. J Invest Dermatol. 1997 Jun;108(6):928-32. doi: 10.1111/1523-1747.ep12294690. J Invest Dermatol. 1997. PMID: 9182824 Free article.

5

Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats.

Safer JD, Fraser LM, Ray S, Holick MF. Safer JD, et al. Among authors: ray s. Thyroid. 2001 Aug;11(8):717-24. doi: 10.1089/10507250152484547. Thyroid. 2001. PMID: 11525263

6

A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.

Peters EM, Foitzik K, Paus R, Ray S, Holick MF. Peters EM, et al. Among authors: ray s. J Invest Dermatol. 2001 Aug;117(2):173-8. doi: 10.1046/j.0022-202x.2001.01410.x. J Invest Dermatol. 2001. PMID: 11511291 Free article.

7

Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial.

Holick MF, Chimeh FN, Ray S. Holick MF, et al. Among authors: ray s. Br J Dermatol. 2003 Aug;149(2):370-6. doi: 10.1046/j.1365-2133.2003.05437.x. Br J Dermatol. 2003. PMID: 12932245 Clinical Trial.

8

Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.

Durakovic C, Ray S, Holick MF. Durakovic C, et al. Among authors: ray s. Br J Dermatol. 2004 Jul;151(1):190-5. doi: 10.1111/j.1365-2133.2004.06002.x. Br J Dermatol. 2004. PMID: 15270890 Clinical Trial.

9

Vitamin D, its precursors, and metabolites do not affect melanization of cultured human melanocytes.

Mansur CP, Gordon PR, Ray S, Holick MF, Gilchrest BA. Mansur CP, et al. Among authors: ray s. J Invest Dermatol. 1988 Jul;91(1):16-21. doi: 10.1111/1523-1747.ep12463282. J Invest Dermatol. 1988. PMID: 3385213 Free article.

10

Photoaffinity labeling of chick intestinal 1 alpha,25-dihydroxyvitamin D3 receptor.

Ray R, Ray S, Rose S, Holick MF. Ray R, et al. Among authors: ray s. Steroids. 1993 Oct;58(10):462-5. doi: 10.1016/0039-128x(93)90003-6. Steroids. 1993. PMID: 8256255 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,794 results

Search Page

Filters